Description metaMe Health is committed to developing FDA-approved prescription digital therapeutics for the treatment of gastrointestinal conditions. Regulora™ for IBS metaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.
Specialties Prescription digital therapeutics for the treatment of gastrointestinal conditions
Address 222 Merchandise Mart Plaza, Chicago, Illinois
Address 60657, United States
Linkedin Source https://www.linkedin.com/company/metame-health